Keio University

Press Release

311-320 items (total 448)
Published At June 16, 2020

Japanese-Developed Surgical Site Antiseptic "Olanexidine" Halves Postoperative Infections—Proven in an Investigator-Initiated Randomized Controlled Trial

Published At June 12, 2020

The Potential of a New CAR-T Cell Therapy for Solid Tumors: Elucidating the High Therapeutic Efficacy and Mechanism of Combination Therapy with CAR-T Cells and an Anti-PD-1 Antibody

Published At June 12, 2020

Elucidation of a Novel Anti-inflammatory Mechanism Mediated by the Autonomic Nervous System: Shedding New Light on the Treatment of Infectious Diseases, Cancer, and Inflammatory Bowel Disease via the Vagus Nerve

Published At June 11, 2020

"Exploratory Clinical Trial of Adipose-derived Stem/Stromal Cell-derived Platelet-like Cells (ASCL-PLC) for Refractory Skin Ulcers" - A Project for the Application of Platelet Production Technology in Regenerative Medicine

Published At June 01, 2020

Potential of Fish Extract as a Therapeutic Agent for Diabetic Retinopathy—A New Approach to Anti-Angiogenic Effects

Published At May 21, 2020

World's First Announcement on the Long-Term Efficacy of a Smartphone App for Smoking Cessation Treatment—Results of Japan's First Clinical Trial for a Therapeutic App—

Published At May 21, 2020

Launch of the Joint Research Group "Japan COVID-19 Task Force"—Promoting R&D of a COVID-19 Mucosal Vaccine Based on Genetic Findings of the Novel Coronavirus Disease—

Published At April 27, 2020

Technological Innovation and Disease Control at the Epicenter of Infectious Diseases! Feasibility Study Begins for Establishing an Overseas Research Center for Infectious Disease Control in the Democratic Republic of the Congo

Published At March 10, 2020

Is Genotype-Guided Personalized Treatment Necessary for Breast Cancer Tamoxifen Therapy? – World's First Prospective Clinical Trial Settles Long-Standing Controversy, Confirming That the Poor Metabolizer Genotype Common in Japanese People Is Not a Therapeutic Disadvantage

Published At February 21, 2020

World's First Elucidation of the Molecular Mechanism of Action Involved in the Anti-inflammatory Effects of Sesamin